Patents/Assignees

AMGEN Inc.

354 patents in portfolio

USD1106445design2025
Handheld Drug Delivery Device
0 cites
US12497666utility2025
Nucleic Acid Biomarker and Use Thereof
0 cites
US12493019utility2025
Methods of Determining Protein Stability
0 cites
US12493943utility2025
Apparatuses, Systems and Methods for Plunger-stopper Depth Measurement in Pre-filled Syringes
0 cites
US12485219utility2025
Drug Delivery Devices with Partial Drug Delivery Member Retraction
0 cites
US12479930utility2025
Proteins Specific for BAFF and B7RP1 and Uses Thereof
0 cites
US12480858utility2025
Automated Visual Inspection
0 cites
US12473281utility2025
Synthesis of KRAS G12C Inhibitor Compound
0 cites
US12473289utility2025
Heterocyclic Compounds as Delta-5 Desaturase Inhibitors and Methods of Use
0 cites
US12473329utility2025
Methods Directed to Crystalline Biomolecules
0 cites
US12465652utility2025
Method of Treating or Ameliorating Metabolic Disorders Using Antagonistic Binding Proteins for Gastric Inhibitory Peptide Receptor (GIPR)/GLP-1 Receptor Agonist Fusion Proteins
0 cites
US12466825utility2025
Synthesis of KRAS G12C Inhibitor Compound
0 cites
US12459932utility2025
KIF18A Inhibitors
0 cites
USD1101191design2025
Vial Sleeve
0 cites
US12459896utility2025
Process for Preparing 4-methyl-2-propan-2-yl-pyridine-3-carbonitrile
0 cites
US12448373utility2025
Azetidinyl-acetamides as CXCR7 Inhibitors
0 cites
US12448396utility2025
Methods of Using Heterocyclic Compounds as Delta-5 Desaturase Inhibitors
0 cites
US12440491utility2025
KRAS G12C Inhibitors and Methods of Using the Same
0 cites
US12440567utility2025
Aqueous Antibody Formulation Stabilized by Antioxidants for Parenteral Administration
0 cites
US12440625utility2025
Drug Delivery Device
0 cites

← PreviousPage 3 of 18Next →